Attitudes of old age psychiatrists in England and Wales to the use of mood stabilizer drugs

International Psychogeriatrics

Volumn 21, Issue 3, 2009, Pages 576-580

  Ephraim, E ^a   Prettyman, R ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Carbamazepine; Elderly; Lamotrigine; Lithium; Mood stabilizer; Valproate

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; OLANZAPINE; QUETIAPINE; VALPROATE SEMISODIUM; VALPROIC ACID; VIGABATRIN; ANTICONVULSIVE AGENT; LITHIUM DERIVATIVE;

ARTICLE; CHEMOPROPHYLAXIS; CLINICAL PRACTICE; DEMENTIA; DEPRESSION; DRUG INDICATION; DRUG SAFETY; DRUG USE; FEMALE; GERONTOPSYCHIATRY; HUMAN; MALE; MANIA; MOOD DISORDER; NORMAL HUMAN; PHYSICIAN ATTITUDE; PSYCHIATRIST; QUESTIONNAIRE; SCHIZOPHRENIA; UNITED KINGDOM; AGED; EPIDEMIOLOGY; HEALTH PERSONNEL ATTITUDE; MENTAL DISEASE; POSTAL MAIL; STATISTICS;

AGED; ANTICONVULSANTS; ATTITUDE OF HEALTH PERSONNEL; ENGLAND; FEMALE; GERIATRIC PSYCHIATRY; GREAT BRITAIN; HEALTH CARE SURVEYS; HUMANS; LITHIUM COMPOUNDS; MALE; MENTAL DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; POSTAL SERVICE; QUESTIONNAIRES; WALES;

EID: 67649097210     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610209008667     Document Type: Article

References (12)

1. Bazire, S. (2007). Psychotropic Drug Directory 2007. Aberdeen: Healthcomm U.K.
2. Committee on Safety of Medicines (2006). New Advice Issued on Risperidone and Olanzapine: Press Release. Available at http://www.mhra.gov.uk; last accessed 3 December 2007.
3. Ferrier, I. N. (2001). Developments in mood stabilizers, depression and public health. British Medical Bulletin, 57, 179-192.
4. Grimm, S. W., Richtand, N. M., Winter, H. R., Stams, K. R. and Reele, S. B. (2006). Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics. British Journal of Clinical Pharmacology 61, 58-69.
5. Guthrie, S. K., Stoysich, A. M., Bader, G. and Hilleman, D. E. (1995). Hypothesized interaction between valproic acid and warfarin. Journal of Clinical Psychopharmacology, 15, 138-139.
6. Johnson, G. (1998). Lithium: early development, toxicity and renal function. Neuropsychopharmacology, 19, 200-205.
7. Katona, C. (2001). Psychotropics and drug interactions in the elderly patient. International Journal of Geriatric Psychiatry, 16 (Suppl. 1), 86-90.
8. National Institute for Health and Clinical Excellence (2002). Clinical Guideline 1: Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. Available at http://www.nice.org.uk/guidance; last accessed 7 December 2007.
9. National Institute for Health and Clinical Excellence (2007). Clinical Guideline 23 (amended): Depression: Management of Depression in Primary and Secondary Care. Available at http://www.nice.org.uk/guidance; last accessed 7 December 2007.
10. Sajatovic, M., Ramsay, E., Nanry, K. and Thompson, T. (2005). Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia. International Journal of Geriatric Psychiatry, 22; 10, 945-950.
11. Shulman, K. I. et al. (2003). Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. BMJ, 326, 960-961.
12. Sibbald, B., Addington-Hall, J., Brenneman, D. and Freeling, P. (1994). Telephone versus postal surveys of general practitioners: methodological considerations. British Journal of General Practice, 44, 297-300. (Pubitemid 24224577)